About this case
Lawsuits claim that Kenvue (the maker of Tylenol) and retailers selling store-brand acetaminophen failed to warn that prenatal use may be linked to autism spectrum disorder (ASD) and ADHD in children. Many medical organizations dispute that link, and it remains contested.
Where the case stands
The federal cases were dismissed in 2023-2024, but on July 13, 2026 the Second Circuit Court of Appeals revived more than 500 lawsuits, returning the litigation to active status.
Status last reviewed November 2026. Lawsuit developments change often.
Who may qualify
- You took Tylenol or generic acetaminophen during pregnancy
- Your child was diagnosed with autism spectrum disorder and/or ADHD
Injuries and conditions involved
Free · Confidential · About 2 minutes
Find out if you qualify
Answer a few quick questions about your Tylenol (APAP) claim. There's no cost and no obligation.
See If I QualifyPrefer to talk? Call (877) 342-6154


